| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.007 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.01 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.02 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |